Abstract | OBJECTIVE: METHODS: Peripheral blood mononuclear cells (PBMC) were isolated from HLA-A2+ healthy donors. The PBMCs were incubated with HPV-16 E7(11-20) peptide and varying cytokines in the primary culture. Restimulation was performed weekly with peptide-pulsed, irradiated autologous PBMCs. Alternatively, the PBMCs were depleted of abundant CD4+ cells and stimulated with HPV-16 E7(11-20) peptide-pulsed dendritic cells. Cytolytic activity was determined by a standard 4-h (51)Cr-release assay. RESULTS: After 6 weeks in culture, we were able to establish peptide-specific CTL lines in one of seven donors by incubating PBMCs with HPV-16 E7(11-20) peptide. When we employed autologous peptide-pulsed dendritic cells to stimulate CD8+ cell-enriched PBMCs, we obtained CTL lines in four of seven donors. The primed CTLs were able to lyse the HLA-A2+ and HPV-16+ cervical cancer cell line Caski. SiHa, an HLA-A2-, but HPV 16+, cervical cancer cell line could be lysed only after transfection with HLA-A2. In addition, a high cytotoxicity (>80%) was obtained against peptide-pulsed, but not unpulsed, targets such as autologous Ebstein-Barr virus-immortalized B cells or allogeneic lipopolysaccaride-stimulated PBMCs. DCs were clearly the most potent of all tested antigen presenting cells to stimulate a CTL response in a proliferation assay. CONCLUSION:
HPV-16 E7 peptide-specific CTLs could be generated in vitro. A practical protocol to expand the CTLs to a sufficient number for an application in a clinical trial is in progress.
|
Authors | W M Schoell, R Mirhashemi, B Liu, M F Janicek, E R Podack, M A Penalver, H E Averette |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 74
Issue 3
Pg. 448-55
(Sep 1999)
ISSN: 0090-8258 [Print] United States |
PMID | 10479508
(Publication Type: Journal Article)
|
Copyright | Copyright 1999 Academic Press. |
Chemical References |
- Oncogene Proteins, Viral
- Papillomavirus E7 Proteins
- oncogene protein E7, Human papillomavirus type 16
|
Topics |
- Dendritic Cells
(immunology)
- Female
- Humans
- Immunotherapy
(methods)
- Oncogene Proteins, Viral
(immunology)
- Papillomaviridae
(immunology)
- Papillomavirus E7 Proteins
- Species Specificity
- T-Lymphocytes, Cytotoxic
- Tumor Cells, Cultured
- Uterine Cervical Neoplasms
(therapy)
|